Cite
HARVARD Citation
Singh, S. et al. (2018). Comparison of infliximab with adalimumab in 827 biologic‐naïve patients with Crohn's disease: a population‐based Danish cohort study. Alimentary pharmacology & therapeutics. 47 (5), pp. 596-604. [Online].